Latest News and Press Releases

STOCKHOLM, Sweden, Aug. 17, 2004 (PRIMEZONE) -- Vitrolife: - Turnover increased by 13 percent, to SEK 55.1 million (48.8). Adjusted for currency effects the increase was 16 percent. During the...

STOCKHOLM, Sweden, Aug. 16, 2004 (PRIMEZONE) -- Vitrolife has been notified that the company's patent application, regarding the use of recombinant albumin with or without hyaluronic acid in media...

STOCKHOLM, Sweden, June 28, 2004 (PRIMEZONE) -- Vitrolife has received European approval (CE mark) for a complete series of products within ART (Assisted Reproductive Technology). "This gives us...

STOCKHOLM, Sweden, June 22, 2004 (PRIMEZONE) -- Anna Ahlberg has been appointed as Head of Vitrolife's accounting and financing department and for investor relations. Anna Ahlberg has worked within...

STOCKHOLM, Sweden, Feb. 2, 2004 (PRIMEZONE) -- Vitrolife's year end report for 2003 will be presented the 17th of February instead of the earlier date preliminary set (12th February) due to a change...

STOCKHOLM, Sweden, August 26, 2003 (PRIMEZONE) -- Vitrolife AB announced today that it has completed the sale of two of its subsidiaries, A-Life Ltd and A-Life Inc, to Mentor Corporation, a global...

STOCKHOLM, Sweden, Aug. 13, 2003 (PRIMEZONE) -- The Board of Directors appointed Dr. Magnus Nilsson CEO of Vitrolife AB (publ). Magnus Nilsson was previously Acting CEO of Vitrolife since January 3,...

STOCKHOLM, Sweden, July 9, 2003 (PRIMEZONE) -- The American Food and Drug Administration (FDA) has approved Vitrolife's application for market clearance, 510(k), for EmbryoGlue(R) developed in close...

STOCKHOLM, Sweden, May 26, 2003 (PRIMEZONE) -- EmbryoGlue(R) is an implantation promoting medium for transfer of embryos back into the woman, with physical properties more similar to the uterine...

STOCKHOLM, Sweden, March 10, 2003 (PRIMEZONE) -- Vitrolife (Stockholm:VITR) inventors have been granted a U.S. Patent for a new cryopreservation technique for viable cells, called loop vitrification....